ALBERT PRICE: Open Payments
NPI 1144329798 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 50 payments from 17 companies in 2025. Trend: 2023 $240 · 2024 $968 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $219 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Novo Nordisk Inc | 5 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Lilly USA, LLC | 4 | $63 |
| Exact Sciences Corporation | 3 | $54 |
| PFIZER INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Amgen Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: QULIPTA, XIFAXAN, UBRELVY, Kerendia, MOUNJARO, Cologuard Collection Kit, Ozempic, BREZTRI.
Industry payments across AR — which companies pay providers there.
